Irbesdak H 150mg/12.5mg Tablet
Marketer
Devak Formulations
Salt Composition
Irbesartan (150mg) + Hydrochlorothiazide (12.5mg)
Overview Irbesdak H 150mg/12.5mg Tablet
Combiflex BP 150mg/12.5mg tablets combine two active ingredients to manage hypertension through complementary mechanisms. Untreated high blood pressure significantly elevates the risk of serious complications like stroke, heart attack, and kidney disease. Combiflex BP 150mg/12.5mg tablets can be taken with or without food, the dosage being tailored to individual needs and response. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial for effective blood pressure control. This medication includes a diuretic component, increasing urination; therefore, avoid taking it within four hours of bedtime. Regular use is vital, even during symptom-free periods, as hypertension often presents asymptomatically. Discontinuing treatment increases the risk of cardiovascular events. Common side effects include dizziness; others, such as fatigue, nausea, diarrhea, stomach upset, headache, and hypotension, are also possible. Increased urination is an expected effect of the diuretic (hydrochlorothiazide) and contributes to blood pressure regulation. While rarer side effects exist, hydrochlorothiazide may, in some cases, elevate intraocular pressure, potentially causing irreversible eye damage if untreated. Always review the accompanying patient information leaflet and consult your doctor regarding any persistent or bothersome side effects. Dosage adjustment or alternative medication may be considered. This medication is generally not recommended during pregnancy or breastfeeding. Individuals with pre-existing kidney or liver conditions, cardiac issues, or diabetes should consult their physician before commencing treatment. Alcohol consumption can exacerbate hypotension and may intensify side effects.
Primary Ingredients of Irbesdak H 150mg/12.5mg Tablet
No information provided. Please provide the text you wish me to rewrite.
Uses of Irbesdak H 150mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Irbesdak H 150mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablet should be swallowed whole; do not chew, crush, or divide it. Irbesdak H 150mg/12.5mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Irbesdak H 150mg/12.5mg Tablet:
- Nausea
- Taste change
- Upset stomach
- Diarrhea
- Weakness
- Dizziness
- Headache
- Glucose intolerance
- Increased blood uric acid
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
How to use Irbesdak H 150mg/12.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Irbesdak H 150mg/12.5mg Tablets can be administered with or without food, though consistent timing is recommended.
How Irbesdak H 150mg/12.5mg Tablet works:
Each Irbesartan/Hydrochlorothiazide 150mg/12.5mg tablet contains a dual formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Irbesartan/Hydrochlorothiazide 150mg/12.5mg tablets and alcohol may induce pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Using Irbesartan/Hydrochlorothiazide 150mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. A physician might exceptionally prescribe it in critical circumstances where potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Irbesartan/Hydrochlorothiazide 150mg/12.5mg tablets during breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Taking Irbesdak H 150mg/12.5mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Irbesdak H 150mg/12.5mg tablets, as dose modification may be necessary. Physician consultation is advised. Irbesdak H 150mg/12.5mg tablets are generally not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Irbesartan/Hydrochlorothiazide 150mg/12.5mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Irbesdak H 150mg/12.5mg Tablet :
Should you forget to take your Irbesdak H 150mg/12.5mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Irbesdak H 150mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently